Logo image of CRL

CHARLES RIVER LABORATORIES (CRL) Stock Analyst Ratings

NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD

118.46  +1.57 (+1.34%)

After market: 118.46 0 (0%)

Buy % Consensus

63

ChartMill assigns a Buy % Consensus number of 63% to CRL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 150.62. This target is 27.15% above the current price.
CRL was analyzed by 24 analysts. The buy percentage consensus is at 63. So analysts seem to be rather neutral about CRL.
In the previous month the buy percentage consensus was at a similar level.
CRL was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
CRL Historical Analyst RatingsCRL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -100 -91 -82 -73 -64 -55 -46 -37 -28 -19 -10 -1 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 118.4670.70153.00150.62225.75 - -40.32% 29.16% 27.15% 90.57%
CRL Current Analyst RatingCRL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-04-10 Barclays Maintains Equal-Weight -> Equal-Weight
2025-04-09 Mizuho Maintains Neutral -> Neutral
2025-03-21 Goldman Sachs Downgrade Buy -> Neutral
2025-03-04 Citigroup Upgrade Sell -> Neutral
2025-02-20 Barclays Maintains Equal-Weight -> Equal-Weight
2025-02-20 JP Morgan Maintains Neutral -> Neutral
2025-02-20 Baird Maintains Neutral -> Neutral
2025-02-18 Barclays Maintains Equal-Weight -> Equal-Weight
2025-02-05 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2025-02-03 JP Morgan Maintains Neutral -> Neutral
2025-01-23 Goldman Sachs Maintains Buy -> Buy
2025-01-22 William Blair Downgrade Outperform -> Market Perform
2025-01-17 UBS Downgrade Buy -> Neutral
2025-01-14 William Blair Reiterate Outperform -> Outperform
2024-12-13 B of A Securities Maintains Neutral -> Neutral
2024-11-11 TD Cowen Maintains Hold -> Hold
2024-11-07 UBS Maintains Buy -> Buy
2024-11-07 Evercore ISI Group Maintains In-Line -> In-Line
2024-10-23 CLSA Initiate Underperform
2024-10-14 Redburn Atlantic Initiate Sell
2024-10-07 Evercore ISI Group Downgrade Outperform -> In-Line
2024-10-02 B of A Securities Downgrade Buy -> Neutral
2024-10-01 Citigroup Downgrade Neutral -> Sell
2024-09-20 Baird Maintains Neutral -> Neutral
2024-08-12 TD Cowen Maintains Hold -> Hold
2024-08-08 UBS Maintains Buy -> Buy
2024-08-08 Barclays Maintains Equal-Weight -> Equal-Weight
2024-08-08 Evercore ISI Group Maintains Outperform -> Outperform
2024-08-08 JP Morgan Downgrade Overweight -> Neutral
2024-08-08 Baird Downgrade Outperform -> Neutral